Add to ORKGThe online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
Jacob C Jentzer,1 Gavin W Hickey,1 Sameer J Khandhar2,3 1Heart and Vascular Institute, Universi...
Background Cardiac allograft vasculopathy (CAV) is characterized by diffuse thickening of the arteri...
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
Abstract Heart transplantation is a well established therapy for end-stage heart failure. Long-term ...
Abstract—Cardiac allograft vasculopathy (CAV) continues to limit the long-term success of cardiac tr...
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
Cardiac transplantation is currently the preferred choice of treatment for end-stage cardiac disease...
Objective: To investigate the modifiable, non-immune risk factors associated with cardiac allograft ...
The online version of this article, along with updated information and services, is located on th
Jacob C Jentzer,1 Gavin W Hickey,1 Sameer J Khandhar2,3 1Heart and Vascular Institute, Universi...
Background Cardiac allograft vasculopathy (CAV) is characterized by diffuse thickening of the arteri...
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
Abstract Heart transplantation is a well established therapy for end-stage heart failure. Long-term ...
Abstract—Cardiac allograft vasculopathy (CAV) continues to limit the long-term success of cardiac tr...
The online version of this article, along with updated information and services, is located on th
The online version of this article, along with updated information and services, is located on th
Cardiac transplantation is currently the preferred choice of treatment for end-stage cardiac disease...
Objective: To investigate the modifiable, non-immune risk factors associated with cardiac allograft ...
The online version of this article, along with updated information and services, is located on th
Jacob C Jentzer,1 Gavin W Hickey,1 Sameer J Khandhar2,3 1Heart and Vascular Institute, Universi...
Background Cardiac allograft vasculopathy (CAV) is characterized by diffuse thickening of the arteri...